To our knowledge, investigations of the episignature of SETD1A and SETD2 NDDs have not been reported previously with an NGS-based methylation profiling strategy but a methylation array-based episignature has been reported for SETD2 (LLS) and SETD1B- related NDD (13,33). The gene discussed is SETD1A; the disease is Neurodevelopmental delay.